[13C6]-Pralatrexate pentaglutamate

Catalog Number	ACMA00065214
Description	Pralatrexate pentaglutamate is intended for Pharmaceuticals applications. Pralatrexate is indicated for the treatment of Peripheral T-cell lymphoma (PTCL). All information about [13C6]-Pralatrexate pentaglutamate is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis.
Molecular Weight	999.9
Molecular Formula	C3713C6H51N11O17
Purity	≥98%
Isotopic Enrichment	99% 13C
Stability	≥1 year

Please kindly note that our products and services are for research use only.

Online Inquiry



mg g kg ml L

[13C6]-Pralatrexate pentaglutamate (ACMA00065214)

SUBMIT